← FDA DRUG APPROVALS

FDA ANDA · ANDA065457

MYCOPHENOLATE MOFETIL

Sponsor: TEVA PHARMS

APPLICATION
ANDA065457
TYPE
ANDA
ORIGINAL APPROVAL
2009-05-04
LATEST ACTION
2026-07-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MYCOPHENOLATE MOFETILDiscontinued
MYCOPHENOLATE MOFETIL 500MG · TABLET · ORAL

Approval history

2026-07-29REMS · Supplement 19AP
2024-08-13REMS · Supplement 18AP
2021-08-11REMS · Supplement 17AP
2021-04-21REMS · Supplement 16AP
2021-01-15REMS · Supplement 13AP
2015-11-13REMS · Supplement 9AP
2015-10-30Labeling · Supplement 10 · standardAP
2013-09-27Labeling · Supplement 6 · standardAP
2012-09-25REMS · Supplement 4AP
2012-07-25Labeling · Supplement 5 · standardAP
2010-02-04Labeling · Supplement 2AP
2010-02-02Labeling · Supplement 1AP
2009-05-04OriginalOther Important Information from FDAAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →